Apr 17 |
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
|
Apr 11 |
KORU Medical Systems announces successful appeal in EU notified body review
|
Apr 11 |
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
|
Mar 15 |
KORU Medical Systems Full Year 2023 Earnings: EPS Misses Expectations
|
Mar 14 |
KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript
|
Mar 13 |
KORU Medical Systems Non-GAAP EPS of -$0.02 beats by $0.02, revenue of $7.2M beats by $0.26M
|
Mar 13 |
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
|
Mar 13 |
Earnings Scheduled For March 13, 2024
|
Mar 11 |
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
|
Mar 6 |
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
|